Pregled bibliografske jedinice broj: 1071221
IL-1beta, IL-6, IL-10, and TNFalpha single nucleotide polymorphisms in human influence the susceptibility to Alzheimer’s disease pathology
IL-1beta, IL-6, IL-10, and TNFalpha single nucleotide polymorphisms in human influence the susceptibility to Alzheimer’s disease pathology // Journal of alzheimers disease, 75 (2020), 3; 1029-1047 doi:10.3233/JAD-200056 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1071221 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
IL-1beta, IL-6, IL-10, and TNFalpha single nucleotide polymorphisms in human influence the susceptibility to Alzheimer’s disease pathology
Autori
Babić Leko, Mirjana ; Nikolac Perković, Matea ; Klepac, Nataša ; Švob Štrac, Dubravka ; Borovečki, Fran ; Pivac, Nela ; Hof, Patrick R. ; Šimić, Goran
Izvornik
Journal of alzheimers disease (1387-2877) 75
(2020), 3;
1029-1047
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
Alzheimer's disease ; biomarkers ; IL-10 ; IL-1 ; IL-6 ; inflammation ; polymorphisms ; TNFalpha
Sažetak
Background: Neuroinflammation plays an important role in Alzheimer’s disease (AD). During this process, activated microglia release pro-inflammatory cytokines such as interleukin (IL)-1α, IL-1β, IL-6 and tumor necrosis factor α (TNFα) that participate in neuron damage, but also anti-inflammatory cytokines (such as IL-10), which maintain homeostasis of immune response. Previous studies showed the association of IL-1α -889C/T (rs1800587), IL-1β -1473G/C (rs1143623), IL-6 -174C/G (rs1800795), IL-10 -1082G/A (rs1800896) and TNFα -308A/G (rs1800629) polymorphisms with AD. Objective: We aimed to investigate whether people with certain IL-1α, IL-1β, IL-6, IL-10 and TNFα genotypes are more prone to develop AD-related pathology, reflected by pathological levels of cerebrospinal fluid (CSF) AD biomarkers including amyloid β1–42 (Aβ1–42), total tau (t‐tau), tau phosphorylated at Thr 181 (p‐tau181), Ser 199 (p‐tau199), and Thr 231 (p‐tau231), and visinin‐like protein 1 (VILIP‐1). Methods: The study included 115 AD patients, 53 patients with mild cognitive impairment (MCI) and 11 healthy controls. The polymorphisms were determined using real-time polymerase chain reaction. Levels of CSF biomarkers were determined by enzyme‐linked immunosorbent assay. Results: A significant increase in p-tau CSF levels was found in patients with the AA IL-10 -1082G/A and GG TNFα -308A/G genotypes, and in carriers of a G allele in IL-1β -1473C/G and IL-6 -174C/G polymorphisms. T-tau levels were increased in carriers of a G allele in IL-1β -1473C/G polymorphism. An increase in VILIP-1 levels was observed in patients with CG and GG IL-1β -1473C/G, GC IL-6 -174C/G and GG TNFα -308A/G genotype. Conclusion: These results suggest that persons carrying certain genotypes in IL10 (-1082G/A), IL1β (1473C/G), IL6 (-174C/G) and TNFα (-308A/G) could be more vulnerable to development of neuroinflammation, and consequently of AD.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti, Kliničke medicinske znanosti, Kognitivna znanost (prirodne, tehničke, biomedicina i zdravstvo, društvene i humanističke znanosti)
POVEZANOST RADA
Projekti:
HRZZ IP-2019-04-3584
HRZZ IP-2014-09-9730
Ustanove:
Medicinski fakultet, Zagreb
Profili:
Mirjana Babić Leko
(autor)
Goran Šimić
(autor)
Fran Borovečki
(autor)
Dubravka Švob Štrac
(autor)
Nela Pivac
(autor)
Nataša Klepac
(autor)
Matea Nikolac Perković
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE